". . .Battelle effectively integrated many elements of our R&D, marketing, quality assurance, regulatory, and manufacturing functions into the product design. The result is an innovative solution that meets the needs of Neoprobe's customers." David Bupp, President/COO, Neoprobe (third from left).

Battelle integrates seamlessly with our clients' internal functions to accelerate medical product development and improve quality. Our reliable, responsive, and cost-effective product development process led to a number of new projects in 1996, including several top priority items for five FORTUNE 500 companies. Battelle's Ohio-based Medical Product Development Group attained ISO 9001 certification this year, a symbol of our commitment to quality results and world-class service. Our acquisition of The Larren Corporation further enhanced our medical device development capabilities. Integrating core technologies from our diverse technical base, Battelle now delivers the most comprehensive medical device technology and development services in the country. Strategic alliances between Battelle and organizations like Plexus Corporation provide added benefits for our clients. The clinical and manufacturing expertise available through our alliances accelerates new product introduction, incorporates breakthrough technologies, and provides quality, cost-effective products. According to Plexus Corporation's President, John Nussbaum, "Battelle integrates manufacturing issues early in the product design process, ensuring smooth transitions and rapid market entry." Battelle also formed the Health Care Advisory Panel in 1996. Comprising industry leaders from medical device firms, health care delivery systems, and payor networks, this panel helps set direction for Battelle, ensuring our focus on emerging medical technology issues.

Calcium phosphate composite bone paste forms a network for healing bone cavities. Our alliance with Plexus facilitates market introduction of electronic medical products. Vascular stents developed at the Pacific Northwest National Laboratory provide structure around which veins or arteries can heal. The stent is absorbed into the body within three weeks.